N6022

DRUG2 trials

Sponsors

Nivalis Therapeutics, Inc.

Conditions

Cystic FibrosisHealthy

Phase 1

Safety and Tolerability Study of N6022 in Healthy Subjects

CompletedNCT01147406

Nivalis Therapeutics, Inc.Healthy

Start: 2010-08-31End: 2011-06-30Updated: 2014-03-07

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

CompletedNCT01746784

Nivalis Therapeutics, Inc.Cystic Fibrosis

Start: 2014-02-28End: 2014-05-31Updated: 2014-11-24